AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $44,609,000 | -31.2% | 1,588,069 | -7.3% | 0.85% | -15.7% |
| Q2 2019 | $64,857,000 | -8.4% | 1,713,069 | -5.6% | 1.00% | -8.4% |
| Q1 2019 | $70,821,000 | +75.4% | 1,815,000 | -4.1% | 1.10% | +46.9% |
| Q4 2018 | $40,369,000 | -53.2% | 1,893,500 | -13.1% | 0.75% | -28.3% |
| Q3 2018 | $86,306,000 | -13.6% | 2,180,000 | -16.6% | 1.04% | -12.8% |
| Q2 2018 | $99,919,000 | -5.6% | 2,615,000 | -25.8% | 1.19% | -9.1% |
| Q1 2018 | $105,839,000 | -18.0% | 3,522,100 | -14.7% | 1.31% | -19.6% |
| Q4 2017 | $129,051,000 | +11.6% | 4,129,638 | 0.0% | 1.63% | +47.7% |
| Q3 2017 | $115,671,000 | +25.9% | 4,129,638 | -14.0% | 1.10% | +14.7% |
| Q2 2017 | $91,855,000 | +12.3% | 4,801,638 | 0.0% | 0.96% | +3.9% |
| Q1 2017 | $81,820,000 | -6.7% | 4,801,638 | 0.0% | 0.93% | -17.1% |
| Q4 2016 | $87,726,000 | +2.6% | 4,801,638 | 0.0% | 1.12% | +14.8% |
| Q3 2016 | $85,517,000 | – | 4,801,638 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |